US Stock MarketDetailed Quotes

Acurx Pharmaceuticals (ACXP)

Watchlist
  • 2.960
  • -0.110-3.58%
Close Apr 8 16:00 ET
  • 2.920
  • -0.040-1.36%
Post 16:48 ET
8.45MMarket Cap-0.56P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acurx Pharmaceuticals (ACXP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.63%-6.79M
47.35%-1.18M
14.10%-1.88M
42.00%-1.67M
33.02%-2.05M
-5.94%-10.38M
46.39%-2.25M
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
Net income from continuing operations
43.51%-7.97M
43.26%-1.58M
29.37%-1.99M
45.50%-2.25M
50.91%-2.15M
3.26%-14.1M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
Change In working capital
-237.62%-390.96K
354.26%17.74K
-238.04%-228.03K
1,396.14%165.31K
-401.30%-345.98K
-71.89%284.09K
97.75%-6.98K
-12.22%165.19K
-98.96%11.05K
62.53%114.83K
-Change in receivables
-96.53%2.71K
-117.75%-8.21K
--0
21.36%-40.21K
-60.42%51.13K
160.42%78.03K
135.81%46.25K
---46.25K
---51.13K
--129.16K
-Change in prepaid assets
167.20%15.11K
222.41%73.18K
-329.63%-104.68K
454.08%108.05K
25.18%-61.45K
-96.45%5.65K
42,135.19%22.7K
388.88%45.59K
-83.28%19.5K
-240.75%-82.13K
-Change in payables and accrued expense
-303.98%-408.78K
37.79%-47.23K
-174.38%-123.35K
128.39%97.47K
-595.04%-335.66K
-79.57%200.4K
58.04%-75.92K
-18.69%165.85K
-95.49%42.68K
451.39%67.8K
Cash from discontinued investing activities
Operating cash flow
34.63%-6.79M
47.35%-1.18M
14.10%-1.88M
42.00%-1.67M
33.02%-2.05M
-5.94%-10.38M
46.39%-2.25M
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
60.78%10.64M
1,356.74%2.83M
8.30%1.72M
865.24%3.09M
-33.73%2.99M
-18.96%6.62M
-95.79%194.55K
1.59M
-90.96%320.21K
4.51M
Net common stock issuance
6.09%6.8M
657.40%1.47M
8.30%1.72M
90.58%610.26K
-30.49%2.99M
7.76%6.41M
-91.90%194.55K
--1.59M
-90.96%320.21K
--4.3M
Proceeds from stock option exercised by employees
1,727.36%3.84M
--1.36M
--0
--2.48M
--0
-90.53%210.2K
--0
--0
--0
--210.2K
Cash from discontinued financing activities
Financing cash flow
60.78%10.64M
1,356.74%2.83M
8.30%1.72M
865.24%3.09M
-33.73%2.99M
-18.96%6.62M
-95.79%194.55K
--1.59M
-90.96%320.21K
--4.51M
Net cash flow
Beginning cash position
-50.41%3.71M
2.50%5.91M
-4.66%6.06M
-47.94%4.64M
-50.41%3.71M
-17.97%7.47M
-18.29%5.76M
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
Current changes in cash
202.17%3.85M
180.22%1.65M
73.70%-157.33K
155.48%1.42M
-35.22%937.17K
-130.07%-3.77M
-587.33%-2.06M
71.42%-598.29K
-230.15%-2.56M
174.85%1.45M
End cash Position
103.85%7.56M
103.85%7.56M
2.50%5.91M
-4.66%6.06M
-47.94%4.64M
-50.41%3.71M
-50.41%3.71M
-18.29%5.76M
-30.45%6.36M
24.27%8.92M
Free cash flow
34.63%-6.79M
47.35%-1.18M
14.10%-1.88M
42.00%-1.67M
33.02%-2.05M
-5.94%-10.38M
46.39%-2.25M
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.63%-6.79M47.35%-1.18M14.10%-1.88M42.00%-1.67M33.02%-2.05M-5.94%-10.38M46.39%-2.25M-4.60%-2.19M-82.68%-2.88M-58.46%-3.06M
Net income from continuing operations 43.51%-7.97M43.26%-1.58M29.37%-1.99M45.50%-2.25M50.91%-2.15M3.26%-14.1M45.61%-2.78M9.42%-2.82M-19.64%-4.12M-50.81%-4.38M
Change In working capital -237.62%-390.96K354.26%17.74K-238.04%-228.03K1,396.14%165.31K-401.30%-345.98K-71.89%284.09K97.75%-6.98K-12.22%165.19K-98.96%11.05K62.53%114.83K
-Change in receivables -96.53%2.71K-117.75%-8.21K--021.36%-40.21K-60.42%51.13K160.42%78.03K135.81%46.25K---46.25K---51.13K--129.16K
-Change in prepaid assets 167.20%15.11K222.41%73.18K-329.63%-104.68K454.08%108.05K25.18%-61.45K-96.45%5.65K42,135.19%22.7K388.88%45.59K-83.28%19.5K-240.75%-82.13K
-Change in payables and accrued expense -303.98%-408.78K37.79%-47.23K-174.38%-123.35K128.39%97.47K-595.04%-335.66K-79.57%200.4K58.04%-75.92K-18.69%165.85K-95.49%42.68K451.39%67.8K
Cash from discontinued investing activities
Operating cash flow 34.63%-6.79M47.35%-1.18M14.10%-1.88M42.00%-1.67M33.02%-2.05M-5.94%-10.38M46.39%-2.25M-4.60%-2.19M-82.68%-2.88M-58.46%-3.06M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 60.78%10.64M1,356.74%2.83M8.30%1.72M865.24%3.09M-33.73%2.99M-18.96%6.62M-95.79%194.55K1.59M-90.96%320.21K4.51M
Net common stock issuance 6.09%6.8M657.40%1.47M8.30%1.72M90.58%610.26K-30.49%2.99M7.76%6.41M-91.90%194.55K--1.59M-90.96%320.21K--4.3M
Proceeds from stock option exercised by employees 1,727.36%3.84M--1.36M--0--2.48M--0-90.53%210.2K--0--0--0--210.2K
Cash from discontinued financing activities
Financing cash flow 60.78%10.64M1,356.74%2.83M8.30%1.72M865.24%3.09M-33.73%2.99M-18.96%6.62M-95.79%194.55K--1.59M-90.96%320.21K--4.51M
Net cash flow
Beginning cash position -50.41%3.71M2.50%5.91M-4.66%6.06M-47.94%4.64M-50.41%3.71M-17.97%7.47M-18.29%5.76M-30.45%6.36M24.27%8.92M-17.97%7.47M
Current changes in cash 202.17%3.85M180.22%1.65M73.70%-157.33K155.48%1.42M-35.22%937.17K-130.07%-3.77M-587.33%-2.06M71.42%-598.29K-230.15%-2.56M174.85%1.45M
End cash Position 103.85%7.56M103.85%7.56M2.50%5.91M-4.66%6.06M-47.94%4.64M-50.41%3.71M-50.41%3.71M-18.29%5.76M-30.45%6.36M24.27%8.92M
Free cash flow 34.63%-6.79M47.35%-1.18M14.10%-1.88M42.00%-1.67M33.02%-2.05M-5.94%-10.38M46.39%-2.25M-4.60%-2.19M-82.68%-2.88M-58.46%-3.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -